Thus, the intraperitoneal administration of a high dose of HNP-1 induces liver endothelial NLRP3/caspase-1 inflammasome activation and subsequently destroys cell junctions, thereby increasing vascular permeability after sepsis onset. The gene discussed is CASP1; the disease is Sepsis.